Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma

KEY POINTS: Many patients with metastatic urothelial carcinoma are deemed cisplatin-ineligible because of reduced kidney function. Options include split-dose cisplatin or carboplatin. There was no significant association between regimen type and AKI. Alternative regimens were associated with higher...

Descripción completa

Detalles Bibliográficos
Autores principales: Côté, Gabrielle, Alqaisi, Husam, Chan, Christopher T, Jiang, Di Maria, Kandel, Christopher, Pelletier, Karyne, Wald, Ron, Sridhar, Srikala S., Kitchlu, Abhijat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547229/
https://www.ncbi.nlm.nih.gov/pubmed/37461133
http://dx.doi.org/10.34067/KID.0000000000000214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547229/
https://www.ncbi.nlm.nih.gov/pubmed/37461133
http://dx.doi.org/10.34067/KID.0000000000000214

Ejemplares similares